Contact this trialFirst, we need to learn more about you.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Rilzabrutinib for Immune Thrombocytopenia
Recruiting1 awardPhase 3
Aurora, Colorado
This trial is testing a drug called rilzabrutinib to see if it can help people with a blood disorder called ITP. The trial will last up to 60 weeks and will involve taking the drug or a placebo twice daily.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.